Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 2/2021

01-02-2021 | Sleeve Gastrectomy | Letter to the Editor

It Takes a Village: Sleeve Gastrectomy in a Patient with Heterotaxy Syndrome and Congenital Heart Disease

Authors: Samantha R. Dewald, Jennie H. Wei, Santiago Horgan, Eduardo Grunvald

Published in: Obesity Surgery | Issue 2/2021

Login to get access

Excerpt

Obesity is a chronic relapsing metabolic disease. Compared with medical therapy, bariatric surgery is an option that has demonstrated superior efficacy for disease reversal, metabolic health improvement, and overall mortality benefits [1, 2]. Some patients may present with complicated conditions that may pose increased perioperative risk. Abdominal anatomic anomalies further challenge the surgical team. Here we present a patient with class 3 obesity, heterotaxy syndrome, and congenital heart disease (CHD) who failed medical weight reduction. With multidisciplinary management, she underwent successful sleeve gastrectomy (SG) without complications. …
Literature
1.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376(7):641–51.CrossRef
2.
Sjöström L, Narbro K, Sjöström D, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;367(8):741–52.CrossRef
3.
Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.PubMedPubMedCentral
4.
Atwez A, Keilani Z. Laparoscopic roux-en-Y gastric bypass in a patient with situs inversus totalis: case report, technical tips and review of the literature. Int J Surg Case Rep. 2018;45:56–62.CrossRef
5.
Fulcher AS, Turner MA. Abdominal manifestations of Situs anomalies in adults. Radiographics. 2002;22(6):1439–56.CrossRef
6.
Peoples WM, Moller JH, Edwards JE. Polysplenia: a review of 146 cases. Pediatr Cardiol. 1983;4:129–37.CrossRef
7.
Shaheen O, Siejka J, Pham DT. Surgical management of obesity in a patient with situs ambiguous. Surg Obes Relat Dis. 2016;12:1758–60.CrossRef
8.
Donatelli G, Constantino F, Dhumane P, et al. Endoscopic gastric balloon: a bridge toward definitive bariatric surgical management of a morbidly obese patient with situs ambiguous and midgut malrotation (with videos). Gastrointest Endosc. 2012;75(1):217–8.CrossRef
9.
Sutherland MJ, Ware SM. Disorders of left-right asymmetry: Heterotaxy and Situs Inversus. Am J Med Genet. 2009;151C:307–17.CrossRef
10.
Shiraishi I, Ichikawa H. Human Heterotaxy syndrome: from molecular genetics to clinical features, management, and prognosis. Circ J. 2012;76:2066–75.CrossRef
11.
Tangren CM, Cripe L, Beekman RH, et al. The combined effects of balloon valvuloplasty and surgical weight loss in treatment of aortic stenosis. J Pediatr Surg. 2007;42:1443–5.CrossRef
12.
The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):1–10.
13.
Moulla Y, Lyros O, Blüher M, et al. Feasibility and safety of bariatric surgery in high-risk patients: a single-center experience. J Obes. 2018;2018:1–6.CrossRef
14.
Aminian A, Jamal MH, Andalib A, et al. Is laparoscopic bariatric surgery a safe option in extremely high-risk morbidly obese patients? J Laparoendosc Adv Surg Tech A. 2015;25(9):707–11.CrossRef
15.
Fuchs HF, Laughter V, Harnsberger CR, et al. Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success. Surg Endosc. 2016;30(1):251–8.CrossRef
16.
Elliott JP, Gray EL, Yu J, et al. Medication use among patients prior to bariatric surgery. Bariatr Surg Pract Patient Care. 2015;10(3):105–9.CrossRef
Metadata
Title
It Takes a Village: Sleeve Gastrectomy in a Patient with Heterotaxy Syndrome and Congenital Heart Disease
Authors
Samantha R. Dewald
Jennie H. Wei
Santiago Horgan
Eduardo Grunvald
Publication date
01-02-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 2/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04855-z

Other articles of this Issue 2/2021

Obesity Surgery 2/2021 Go to the issue

Original Contributions

Laparoscopic Roux-en-Y Gastric Bypass for Failed Gastric Banding: One-Step or Two-Step Revisional Surgery?

Original Contributions

Early Weight Loss Following Laparoscopic Sleeve Gastrectomy Is Predictive of Long-Term Weight Loss in Morbidly Obese Chinese

Letter to the Editor

Letter to the Editor Regarding the Mini Gastric Bypass-One Anastomosis Gastric Bypass (MGB-OAGB) IFSO Position Statement

Original Contributions

Haemoglobin and Hematinic Status Before and After Bariatric Surgery over 4 years of Follow-Up

Original Contributions

Challenges in the Diagnosis of Leak After Sleeve Gastrectomy: Clinical Presentation, Laboratory, and Radiological Findings

Biography

Sonja Chiappetta, MD, PhD